Nanocarriers for Targeted Therapy and Management of Ovarian Cancer

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Dr. Swapnil Sharma is a Professor in the Department of Pharmacy at Banasthali Vidyapith, Banasthali, Rajasthan, India. With over 19 years of academic and professional experience, he specializes in fundamental preclinical pharmacology. He has published over 250 research papers, contributed 10+ book chapters, and holds five granted patents, including 1 US and 1 European Patent. He has guided dozens of Ph.D. and several PG scholars. Also, he is a regular reviewer of various peer review journals belonging to various renowned publishing houses .Dr. Dinky Gajiwala is a consultant medical oncologist at Nirali Cancer Hospital, Navsari, with comprehensive clinical expertise in the management of adult solid tumors and hematological malignancies, including breast, gynecological, gastrointestinal, thoracic, urological, head-and-neck cancers, sarcomas, lymphoma, myeloma, and leukemia. She completed her MBBS from Veer Narmad South Gujarat University, followed by DNB Internal Medicine training at Holy Family Hospital and DNB Medical Oncology at Prince Aly Khan Hospital. Her clinical practice includes administration of chemotherapy, targeted therapy, immunotherapy, and palliative oncology care, along with procedures such as intrathecal chemotherapy and peripherally inserted central catheter placement. She is also experienced in both autologous and allogeneic bone marrow transplantation. Dr. Gajiwala actively participates in international oncology communities and is a member of European Society for Medical Oncology, American Society of Clinical Oncology, and Indian Society of Medical and Pediatric Oncology.

• 1. Clinical Landscape of Ovarian Cancer and Opportunities for Nanomedicine2. Ovarian Cancer Biology and Molecular Targets for Nanocarrier Delivery3. Liposomes as Nanocarriers for Ovarian Cancer Therapy4. Solid Lipid Nanoparticles for Controlled Delivery in Ovarian Cancer5. Polymeric Nanoparticles for Ovarian Cancer Management6. Polymeric Micelles for Targeted Delivery7. Dendrimers as Nanoscale Delivery Systems8. Mesoporous Silica Nanoparticles in Ovarian Cancer Therapy9. Niosomes and Ethosomes in Ovarian Cancer Management10. Nanogel Based Delivery Systems11. Hydrogel Based Nanocarriers for Localized Therapy12. Exosome and Extracellular Vesicle Based Nanocarriers13. Artificial Intelligence in Nanocarrier Design and Ovarian Cancer Management14. Regulatory Science and Translational Bottlenecks15. Clinical Trial Landscape of Nanomedicine in Ovarian Cancer16. Pharmacokinetics, Biodistribution, and Safety Profiling17. Clinical Integration of Nanomedicine in Ovarian Cancer Care